References
- R. Injac and B. Strukelj, Recent advances in protection against doxorubicin-induced toxicity, Technol. Cancer Res. Treat. 7 (2008) 497–516; https://doi.org/10.1177/153303460800700611
- C. Carvalho, R. X. Santos, S. Cardoso, S. Correia, P. J. Oliveira, M. S. Santos and P. I. Moreira, Doxorubicin: The good, the bad and the ugly effect, Curr. Med. Chem. 16(25) (2009) 3267–3285; https://doi.org/10.2174/092986709788803312
- R. Injac, Potential medical use of fullerenols after two decades of oncology research, Technol. Cancer Res. Treat. 22 (2023) 1–21; https://doi.org/10.1177/15330338231201515
- R. Injac, M. Perse, N. Obermajer, V. Djordjevic-Milic, M. Prijatelj, A. Djordjevic, A. Cerar, and B. Strukelj, Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas, Biomaterials 29(24–25) (2008) 3451–3460; https://doi.org/10.1016/j.biomaterials.2008.04.048
- R. Injac, M. Perse, M. Cerne, N. Potocnik, N. Radic, B. Govedarica, A. Djordjevic, A. Cerar and B. Strukelj, Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer, Biomaterials 30(6) (2009) 1184–1196; https://doi.org/10.1016/j.biomaterials.2008.10.060
- R. Injac, M. Perse, M. Boskovic, V. Djordjevic-Milic, A. Djordjevic, A. Hvala, A. Cerar and B. Strukelj, Cardioprotective effects of fullerenol C60(OH)24 on a single dose doxorubicin induced cardiotoxicity in rats with malignant neoplasm, Technol. Cancer Res. Treat. 7(1) (2008) 15–26; https://doi.org/10.1177/153303460800700102
- Z. Zhang, Y. Zhang, S. Song, L. Yin, D. Sun and J. Gu, Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals, J. Sep. Sci. 43(9–10) (2020) 1978–1997; https://doi.org/10.1002/jssc.201901340
- Y. Xiao, Y. Wanxiang, H. Xiufen, C. Zuanguang, W. Shumei and Z. Haiyun, Sensitive analysis of doxorubicin and curcumin by micellar electromagnetic chromatography with a double wavelength excitation source, Anal. Bioanal. Chem. 413 (2021) 469–478; https://doi.org/10.1007/s00216-020-03017-5
- S. M. Ansar and T. Mudalige, Direct and simultaneous determination of intra-liposomal and external sulfate in liposomal doxorubicin formulations by capillary electrophoresis/inductively coupled plasma-tandem mass spectrometry (CE/ICP-MS/MS), Int. J. Pharm. 561 (2019) 283–288; https://doi.org/10.1016/j.ijpharm.2019.03.003
- M. Alizadeh, M. Hasanzadeh, J. Soleymani, J. V. Gharamaleki and A. Jouyban, Application of bioactive cyclic oligosaccharide on the detection of doxorubicin hydrochloride in unprocessed human plasma sample: A new platform towards efficient chemotherapy, Microchem. J. 145 (2019) 450–455; https://doi.org/10.1016/j.microc.2018.11.012
- J. A. Ho, N. Fan, A. F. Jou, L. Wu and T. Sun, Monitoring the subcellular localization of doxorubicin in CHO-K1 using MEKC-LIF: Liposomal carrier for enhanced drug delivery, Talanta 99 (2012) 683–688; https://doi.org/10.1016/j.talanta.2012.06.077
- N. Guichard, M. Ogereau, L. Falaschi, S. Rudaz, J. Schappler, P. Bonnabry and S. Fleury-Souverain, Determination of 16 antineoplastic drugs by capillary electrophoresis with UV detection: Applications in quality control, Electrophoresis 39(20) (2018) 2512–2520; https://doi.org/10.1002/elps.201800007
- J. Mbuna and T. Kaneta, Capillary electrophoresis with laser-induced fluorescence detection for application in intracellular investigation of anthracyclines and multidrug resistance proteins, Anal. Sci. 31 (2015) 1121–1128; https://doi.org/10.2116/analsci.31.1121
- Y. Shakalisava and F. Regan, CE separation approaches for combinations of anthracyclines and taxanes, Electrophoresis 30(17) (2009) 3110–3113; https://doi.org/10.1002/elps.200900097
- N. Kishikawa and N. Kuroda, Analytical techniques for the determination of biologically active quinones in biological and environmental samples, J. Pharm. Biomed. Anal. 87 (2014) 261–270; https://doi.org/10.1016/j.jpba.2013.05.035
- C. L. Flurer, Analysis of antibiotics by capillary electrophoresis, Electrophoresis 24(22-23) (2003) 4116–4127; https://doi.org/10.1002/elps.200305639
- G. Zagotto, B. Gatto, S. Moro, C. Sissi and M. Palumbo, Anthracyclines: recent developments in their separation and quantitation, J. Chromatogr. B 764(1-2) (2001) 161–171; https://doi.org/10.1016/s0378-4347(01)00346-2
- K. E. Maudensa, C. P. Stove and W. E. Lambert, Quantitative liquid chromatographic analysis of anthracyclines in biological fluids, J. Chromatogr. B 879(25) (2011) 2471–2486; https://doi.org/10.1016/j.jchromb.2011.07.010
- E. Koziolova, O. Janouskova, P. Chytil, M. Studenovsky, L. Kostka and T. Etrych, Nanotherapeutics with anthracyclines: methods of determination and quantification of anthracyclines in biological samples, Physiol. Res. 64 (2015) S1-S10; https://doi.org/10.33549/physiolres.933140
- P. M. Loadman and C. R. Calabrese, Separation methods for anthraquinone related anti-cancer drugs, J. Chromatogr. B 764(1-2) (2001) 193–206; https://doi.org/10.1016/s0378-4347(01)00281-x
- L. Xiao-Pan, S. Wen-Qian, L. Tong-Xin, L. Bing-Bing and C. Chang-Po, Fullerenol as a water-soluble MALDI-MS matrix for rapid analysis of small molecules and efficient quantification of saccharin sodium in foods, J. Chromatogr. B 1178 (2021) Article ID 122819; https://doi.org/10.1016/j.jchromb.2021.122819
- H. Härmä, S. Laakso, S. Pihlasalo and P. Hänninen, A fluorometric fullerenol sensor for rapid detection of ionic and non-ionic surfactants, Tenside Surfact. Det. 47 (2010) 40–42; https://doi.org/10.3139/113.110052
- F. N. Tomilin, P. V. Artyushenko, I. A. Shchugoreva, A. V. Rogova, N. G. Vnukova, G. N. Churilov, N. P. Shestakov, O. N. Tchaikovskaya, S. G. Ovchinnikov and P. V. Avramov, Structure and vibrational spectroscopy of C82 fullerenol valent isomers: An experimental and theoretical joint study, Molecules 28(4) (2023) Article ID 1569 (11 pages); https://doi.org/10.3390/molecules28041569
- United States Pharmacopeia, 43th Ed., National Formulary, 38th Ed., USP Convention, Rockville (MD), USA, 2020; http://www.usp.org; last access date October 2022
- ICH Q2(R2) Guideline on Validation of Analytical Procedures, Step 5 – Revision 1, EMA/CHMP/ICH, Amsterdam, December 2023; https://www.ema.europa.eu/en/documents/scientific-guideline/ichq2r2-guideline-validation-analytical-procedures-step-5-revision-1_en.pdf; last access date March 2024
- R. Injac, N. Kocevar and S. Kreft, Precision of micellar electrokinetic capillary chromatography in the determination of seven antibiotics in pharmaceuticals and feedstuffs, Anal. Chim. Acta 594(1) (2007) 119−127; https://doi.org/10.1016/j.aca.2007.05.003
- R. Injac, M. Boskovic, N. Kocevar and T. Vovk, Comparative study of robustness between micellar electrokinetic capillary chromatography and high-performance liquid chromatography using one-variable-at-a-time and a new multi-variable-at-a-time approach, Anal. Chim. Acta 620(1-2) (2008) 150−161; https://doi.org/10.1016/j.aca.2008.05.007
- M. Kelley and B. DeSilva, Key elements of bioanalytical method validation for macromolecules, AAPS J. 9 (2007) Article ID 17 (E156-E163); https://doi.org/10.1208/aapsj0902017
- Z. Wang, X. Chang, Z. Lu, M. Gu, Y. Zhao and X. Gao, A precision structural model for fullerenol, Chem. Sci. 5(8) (2014) 2909-3340; https://doi.org/10.1039/c4sc00584h
- ICH Guideline M10 on Bioanalytical Method Validation and Study Sample Analysis, Step5, EMA/CHMP/ ICH, Amsterdam, July 2022; https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf; last access date March 2024
- Bioanalytical Method Validation – Guidance for Industry, FDA/CDER/CVM, Silver Spring (MD) and Rockville (MD), USA, May 2018; https://www.fda.gov/media/70858/download; last access date March 2024
- Q2(R2) Validation of Analytical Procedures - Guidance for Industry, FDA/CDER/CBER, Silver Spring (MD), USA, March 2024; https://www.fda.gov/media/161201/download; last access date April 2024
- J. Methaneethorn, K. Tengcharoen, N. Leelakanok and R. AlEjielat, Population pharmacokinetics of doxorubicin: A systematic review, Asia-Pac. J. Clin. Oncol. 19(1) (2023) 9–26; https://doi.org/10.1111/ajco.13776